ADS VeriChip Marketing Campaign Gets Under FDA’s Skin – Warning Letter

Applied Digital Solutions' VeriChip subcutaneous, microchip-based information repository could pose minor health risks and likely would be deemed Class II with special controls under Center for Devices & Radiological Health oversight, device center reps suggest